Celebrating canSAR: The Largest Public Cancer Drug Discovery Resource in the World
Since its release in 2011, canSAR has become the largest, public, cancer drug discovery resource in the world. It brings together billions of pieces of experimental data across disciplines – biology, chemistry, pharmacology, structural biology, cell biology – with clinical insights. Scientists Dr. Albert Antolin, Dr. Adam Sharp and Dr. Daniela Dolciami, from The Institute of Cancer Research, describe how canSAR is transforming drug discovery.
